Eribulin use in MBC (Metastatic breast cancer) in resource limited setting

被引：0
|
作者：
Roy, Rakesh [1 ]
Sarkar, Abhijit [1 ]
机构：
[1] Saroj Gupta Canc Ctr & Res Inst, Med Oncol Dept, Kolkata, India
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz343.115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3 - 104
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Eribulin in Recurrent/Metastatic Breast Cancer (MBC)
    Taha Sethjiwala
    Manikandan Dhanushkodi
    Venkatraman Radhakrishnan
    Jayachandran Perumal Kalaiarasi
    Nikita Mehra
    Archit Joshi
    Arun Kumar Rajan
    Gangothri Selvarajan
    Balasubramanian Ananthi
    Priya Iyer
    Geetha Senguttuvan
    Bharathi Srilatha
    Arvind Krishnamurthy
    Sridevi Velusamy
    Selvaluxmy Ganesarajah
    Trivadi S. Ganesan
    Tenali Gnana Sagar
    Indian Journal of Gynecologic Oncology, 2019, 17
  • [2] Eribulin in Recurrent/Metastatic Breast Cancer (MBC)
    Sethjiwala, Taha
    Dhanushkodi, Manikandan
    Radhakrishnan, Venkatraman
    Kalaiarasi, Jayachandran Perumal
    Mehra, Nikita
    Joshi, Archit
    Rajan, Arun Kumar
    Selvarajan, Gangothri
    Ananthi, Balasubramanian
    Iyer, Priya
    Senguttuvan, Geetha
    Srilatha, Bharathi
    Krishnamurthy, Arvind
    Velusamy, Sridevi
    Ganesarajah, Selvaluxmy
    Ganesan, Trivadi S.
    Sagar, Tenali Gnana
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 17 (03)
  • [3] Off-label capecitabine, eribulin, or ixabepilone use in metastatic breast cancer (MBC).
    Bobolts, Laura Rose
    Kumar, Akhil
    Fishman, Marc L.
    Shimp, William S.
    Krook, James Edward
    Fishman, Val
    Davis, Sharon
    Anthony, Carol
    Walton, Robert
    Huff, Dinah
    Hrushesky, William John Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Phase Ib study of eribulin (ERB) and cyclophosphamide (CTX) in metastatic breast cancer (MBC).
    Truong, Thach-Giao
    Pelayo, Michael
    Grabowsky, Jennifer A.
    Melisko, Michelle E.
    Magbanua, Mark Jesus Mendoza
    Moasser, Mark M.
    Reinert, Anne
    Hwang, Jimmy
    Park, John W.
    Munster, Pamela N.
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [5] Phase Ib study of eribulin (ERB) and cyclophosphamide (CTX) in metastatic breast cancer (MBC)
    Thach-Giao Truong
    Pelayo, Michael
    Grabowsky, Jennifer A.
    Melisko, Michelle E.
    Magbanua, Mark Jesus Mendoza
    Moasser, Mark M.
    Reinert, Anne
    Hwang, Jimmy
    Park, John W.
    Munster, Pamela N.
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Community use of anthracyclines in metastatic breast cancer (MBC)
    Crook, James Edward
    Kumar, Akhil
    Fishman, Marc L.
    Shimp, William S.
    Bobolts, Laura Rose
    Fishman, Val
    Davis, Sharon
    Huff, Dinah
    Anthony, Carol
    Walton, Robert
    Hrushesky, William J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Multicenter study of the eValuation of Eribulin (E) use in Sicily in metastatic breast cancer (MBC): A Prospective RegistrY (VESPRY trial)
    Adamo, V.
    Ricciardi, G. R. R.
    Franchina, V.
    Ferraro, G.
    Caruso, M.
    Bronte, G.
    Banna, G. L.
    Spadaro, P.
    Savarino, A.
    Iacono, C.
    Parra, H. J. Soto
    Spada, M.
    Safina, V.
    Blasi, L.
    Zerilli, F.
    Prestifilippo, A.
    Giannitto-Giorgio, C.
    Alberio, D.
    Cottini, L.
    Russo, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 20 - 20
  • [8] Multicenter study of the evaluation of eribulin (E) use in Sicily in metastatic breast cancer (MBC): A prospective registry (VESPRY trial).
    Adamo, Vincenzo
    Ricciardi, Giuseppina
    Giuffrida, Dario
    Scandurra, Giuseppa
    Russo, Antonio
    Blasi, Livio
    Spadaro, Pietro
    Lucenti, Antonio
    Parra, Hector J. Soto
    Savarino, Antonino
    Ferrau, Francesco
    Zerilli, Filippo
    Verderame, Francesco
    Butera, Alfredo
    Franchina, Veronica
    Cottini, Lorenzo
    Fedele, Guido
    Caruso, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Absolute lymphocyte count (ALC) is a predictor of eribulin benefit in advanced or metastatic breast cancer (MBC)
    Cortes, Javier
    Manuel Perez-Garcia, Jose
    Nomoto, Kenichi
    Alexis, Karenza
    Saito, Kenichi
    Yoshimura, Yuta
    Muramoto, Kenzo
    Miyoshi, Yasuo
    CANCER RESEARCH, 2020, 80 (04)
  • [10] Real-world analysis of eribulin in metastatic breast cancer (MBC): An assessment of time to treatment failure (TTF) in a community oncology setting
    Dranitsaris, George
    Tripathy, Debu
    Beegle, Nancy L.
    Kalberer, Traci L.
    Cox, John David
    Faria, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
12345